MODERATE TO SEVERE ATOPIC DERMATITIS
Clinical trials for MODERATE TO SEVERE ATOPIC DERMATITIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE ATOPIC DERMATITIS trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE ATOPIC DERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection tested for severe skin condition
Disease control Recruiting nowThis early-stage study is testing a new injectable drug called TRB-061 to see if it's safe for people. First, healthy volunteers will receive single or multiple doses. Then, people with moderate-to-severe eczema will receive four injections over 12 weeks to check for side effects…
Matched conditions: MODERATE TO SEVERE ATOPIC DERMATITIS
Phase: PHASE1 • Sponsor: TRex Bio, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
New injection aims to tame severe eczema itch and rash
Disease control Recruiting nowThis study is testing an investigational injection called SHR-1819 to see if it can safely reduce the skin rash and severe itching caused by moderate-to-severe atopic dermatitis (eczema). About 200 adult participants will be randomly assigned to receive either the study drug or a…
Matched conditions: MODERATE TO SEVERE ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New shot aims to tame severe skin rash
Disease control Recruiting nowThis study is testing whether an experimental injection called SHR-1905 can safely reduce the severity of moderate-to-severe eczema (atopic dermatitis). About 75 adults with this chronic skin condition will receive either the real injection or a placebo to compare results. Resear…
Matched conditions: MODERATE TO SEVERE ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC